Collaborative research led by ARG's Medical Affairs Team and Scientific Advisory Board reinforces the company's commitment to ...
TUCSON, AZ / ACCESS Newswire / February 2, 2026 / Umbrella Labs today announced an expanded research procurement program for ...
Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to its structural fidelity to the endogenous GHRH fragment responsible for in ...
Stefan Bornstein, MD, PhD, professor, made it clear during a press conference at the 67th Congress of the German Society of Endocrinology (DGE) that there is more than one interaction between them.
Association of circulating T lymphocytes and their functional states with pathologic complete response (pCR) in breast cancer (BC). A prospective Italian study. This is an ASCO Meeting Abstract from ...
In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results